Zobrazeno 1 - 7
of 7
pro vyhledávání: '"C M, Arbeeny"'
Autor:
C M Arbeeny, H A Eder
Publikováno v:
Journal of Lipid Research, Vol 24, Iss 11, Pp 1457-1467 (1983)
Studies were performed to determine the mechanism of hepatic removal of a cholesterol-rich beta-migrating lipoprotein. This fraction, designated IDLc, was isolated from the serum of cholesterol-fed diabetic rats by ultracentrifugation at d 1.006-1.03
Externí odkaz:
https://doaj.org/article/c02ecd1e66b74e09b0c7b24fb00434bc
Autor:
A K, Sinha, L A, Scharschmidt, R, Neuwirth, H, Holthofer, N, Gibbons, C M, Arbeeny, D, Schlondorff
Publikováno v:
Journal of lipid research. 31(7)
The mechanisms responsible for hyperfiltration in diabetes mellitus (DM) as well as for the initiation and progression of diabetic nephropathy are not fully elucidated. Enhanced prostaglandin E2 (PGE2) production has been invoked in the former and th
Publikováno v:
Diabetes. 29:774-777
Autor:
C M Arbeeny, V A Rifici
Publikováno v:
Journal of Biological Chemistry. 259:9662-9666
The regulation of the hepatic uptake of chylomicron remnants and very-low-density lipoprotein (VLDL) remnants was studied in the rat using a nonrecirculating liver perfusion system. The hepatic removal of remnant lipoproteins was shown to be by recep
Autor:
H A Eder, C M Arbeeny
Publikováno v:
Journal of Biological Chemistry. 255:10547-10550
Large doses of 17 alpha-ethinyl estradiol were administered to rats made diabetic by administration of streptozotocin and fed a diet containing 2% cholesterol and 1% cholic acid. Before estrogen treatment, these rats were severely hypercholesterolemi
Publikováno v:
The Journal of Cell Biology
Receptor-mediated hepatic uptake of low density lipoproteins (LDL) conjugated to colloidal gold was studied by perfusion of livers from rats treated for 5 d with 17 alpha-ethinylestradiol. Estrogen treatment resulted in a marked decrease in serum lip
Autor:
C M, Arbeeny, H A, Eder
Publikováno v:
The Journal of biological chemistry. 255(22)
Large doses of 17 alpha-ethinyl estradiol were administered to rats made diabetic by administration of streptozotocin and fed a diet containing 2% cholesterol and 1% cholic acid. Before estrogen treatment, these rats were severely hypercholesterolemi